Biophan Technologies, Inc.

Eastman-kodak Company

Nanoset LLC

Medtronic, Inc.

Biomed Solutions, LLC

Biopham Technologies Inc.

Jeffrey L Helfer

Stuart Gilmour MacDonald

Michael L Weiner

Patrick Connelly

Xingwu Wang

Victor R Miller

Robert W Gray

Lee F Frank

Howard J Greenwald

Paul Wagner

Mark J Devaney, Jr

Haribhajan S Kocher

Christopher Thomas

Johannes J Porte

Ronald E Miller

Andrew W Custer

Michael B Kim

Richard L Columbus

Thomas C Jessop

Steven C Switalski

Jeffrey A Wellman

Hsue-Yang Liu

John S Lercher

George W Anstadt

Stuart G MacDoanld

George L Anstadt

Frank G Shellock

Mark P Anstadt

Haribbajan S Kocher

Robert R Osburn

David H Middleton

Victor Miller

Patrick R Connelly

A process for treating biological targets in a fluid of a biological organism, including introducing a fluid comprising a biological target to an assembly comprising an inlet connected to receive the fluid and an outlet connected to pass the fluid from the assembly, wherein the assembly comprises a flow chamber for conveying a flow of the fluid, and a capture zone comprising a target-specific binding agent, wherein during flow of the fluid through the flow chamber, the biological target undergoes flux rolling along the target-specific binding agent.

Process for in vivo treatment of specific biological targets in bodily fluids

An electromagnetic shield has a first patterned or apertured layer having non-conductive materials and conductive material and a second patterned or apertured layer having non-conductive materials and conductive material. The conductive material may be a metal, a carbon composite, or a polymer composite. The non-conductive materials in the first patterned or apertured layer may be randomly located or located in a predetermined segmented pattern such that the non-conductive materials in the first patterned or apertured layer are located in a predetermined segmented pattern with respect to locations of the non-conductive materials in the second patterned or apertured layer.

Device and method for preventing magnetic-resonance imaging induced damage

A process for assisting the function of a heart disposed within a body, and comprising an outer wall, comprising the steps of measuring at least one parameter that is indicative of the function of the heart, applying a compressive force to a portion of the outer wall of the heart, and applying an expansive force to the portion of the outer wall of the heart. The process is preferably performed with an apparatus comprising a cup-shaped shell having an exterior wall, an interior wall, an apex, and an upper edge; a liner having an outer surface and an inner surface, an upper edge joined to said interior wall of the cup-shaped shell, and a lower edge joined of the interior wall of the cup-shaped shell, thereby forming a cavity between the outer surface thereof and the interior wall of the shell; and a drive fluid cyclically interposed within the cavity, the drive fluid applying a uniform force on a portion of the outer wall of the heart.

Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device

An assembly for shielding an implanted medical device from the effects of high-frequency radiation and for emitting magnetic resonance signals during magnetic resonance imaging. The assembly includes an implanted medical device and a magnetic shield comprised of nanomagnetic material disposed between the medical device and the high-frequency radiation. In one embodiment, the magnetic resonance signals are detected by a receiver, which is thus able to locate the implanted medical device within a biological organism.

Magnetic resonance imaging coated assembly

A medical assembly includes a multi-wire lead having a plurality of coiling loops. The multi-wire lead has a gap region and a non-gap region. The gap region has adjacent coiling loops of the multi-wire lead with gaps therebetween so as to form different impedance in the gap region than impedance in the non-gap region. The non-gap region has adjacent coiling loops of the multi-wire lead with no gaps therebetween. The gaps may provide inter-loop capacitance. The multi-wire lead may have a plurality of gap regions, each gap region having a non-gap region therebetween.

Magnetic resonance imaging interference immune device

An assembly for delivering optical signals comprising a nuclear magnetic resonance system comprised of magnets, an NMR programmable logic unit, a signal input channel, and a command output channel; an optical interface assembly electrically connected to the nuclear magnetic resonance system, the optical interface assembly comprising a first laser modulated so as to produce laser optical signals, an interface optical to electrical signal convertor; and a catheter assembly connected to said optical interface assembly, the catheter assembly comprising a proximal end, a distal end, a fiber optic cable assembly, an electronics assembly disposed at the distal end comprised of a catheter electrical to optical signal convertor and a catheter optical to electrical signal convertor, and a first receiving coil disposed at the distal end.

Optical MRI catheter system

A medical device includes a pattern of electrically conductive material. The pattern of electrically conductive material has an anti-antenna geometrical shape such that the anti-antenna geometrical shape substantially prevents the medical device from creating an imaging artifact and/or substantially allows imaging of a volume within the medical device. The pattern may be formed by multiple 'figure-8' shaped electrical conductors, multiple 'figure-8' emulating electrical conductors, multiple sine-wave-like shaped electrical conductors, multiple zig-zag patterned electrical conductors, by multiple electrical conductors, each having sequential conductive loops, and/or a single conductor weaved into a loop mesh. The electrically conductive material may be titanium, tantalum, nitinol, stainless steel, and/or NbZr.

Electromagnetic radiation transparent device and method of making thereof

A shielded medical device implanted in a biological organism. The device has a magnetic shield, and the magnetic shield contains a layer of nanomagnetic material; such layer has a morphological density of at least 98 percent; and it is bonded to the medical device by means of an interlayer with a thickness of less than about 10 microns. The nanomagnetic material in such layer has a saturation magnetization of from about 1 to about 36,000 Gauss, a coercive force of from about 0.01 to about 5,000 Oersteds, a relative magnetic permeability of from about 1 to about 500,000, and an average particle size of less than about 100 nanometers.

Magnetically shielded assembly

A shielded medical device implanted in a biological organism. The device has a magnetic shield, and the magnetic shield contains a layer of nanomagnetic material; such layer has a morphological density of at least 98 percent. The nanomagnetic material in such layer has a saturation magnetization of from about 1 to about 36,000 Gauss, a coercive force of from about 0.01 to about 5,000 Oersteds, a a relative magnetic permeability of from about 1 to about 500,000, and an average particle size of less than about 100 nanometers.

An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.

Electromagnetic interference immune tissue invasive system

An implantable device that contains a power source, a device for producing electrical signals, and a conductor assembly for communicating the electrical signals to biological matter. The conductor assembly contains of a conductor that is capable of being flexed at least about 15 degrees and that has a resistivity at 20 degrees Centigrade of from about 1 to about 100 micro ohm-centimeters. The conductor assembly also contains a magnetic shield located above the flexible conductor; the magnetic shield contains an antithrombogenic composition. The magnetic shield also contains a magnetic shielding material that has a magnetic shielding factor of at least about 0.5.

Implantable shielded medical device

Growing community of inventors

Webster, NY, United States of America

Jeffrey L Helfer